Search: |
Associate Professor : Tamaki, Masanori |
○ | Life sciences [Nephrology] |
1. | MATSUDA Noritake, Hideki Otsuka, Ryosuke Kasai, Tamaki Otani, BOLLOS CHRISTINE ANNE LEAH LOCSIN, Shota Azane, Yamato Kunikane, Youichi Otomi, UEKI Yuya, Mana Okabe, Masafumi Amano, Masanori Tamaki, Shu Wakino, Shoichiro Takao and Masafumi Harada : Quantitative evaluation of 67Gacitrate scintigraphy in the management of nephritis, Scientific Reports, Vol.14, No.16313, 16313, 2024. (Tokushima University Institutional Repository: 119491, DOI: 10.1038/s41598-024-66823-2, PubMed: 39009630, CiNii: 1050019590267929472) |
|
2. | Kazuhiro Hasegawa, Masanori Tamaki, Yusuke Sakamaki and Shu Wakino : Deficiency Causes Mitoribosome Excess in Diabetic Nephropathy Mediated by Transcriptional Repressor HIC1., International Journal of Molecular Sciences, Vol.25, No.12, 2024. (Tokushima University Institutional Repository: 119529, DOI: 10.3390/ijms25126384, PubMed: 38928090) |
|
3. | Kazuhiro Hasegawa, Masanori Tamaki, Eriko Shibata, Taizo Inagaki, Masanori Minato, Sumiyo Yamaguchi, Ikuko Shimizu, Shinji Miyakami, Miho Tada and Shu Wakino : Ability of NAD and Sirt1 to epigenetically suppress albuminuria., Clinical and Experimental Nephrology, Vol.28, No.7, 599-607, 2024. (Tokushima University Institutional Repository: 119528, DOI: 10.1007/s10157-024-02502-w, PubMed: 38587753) |
|
4. | Kazuhiro Hasegawa, Yusuke Sakamaki, Masanori Tamaki and Shu Wakino : PCK1 Protects against Mitoribosomal Defects in Diabetic Nephropathy in Mouse Models., Journal of the American Society of Nephrology, Vol.34, No.8, 1343-1365, 2023. (DOI: 10.1681/ASN.0000000000000156, PubMed: 37199399) |
|
5. | Masanori Minato, Taichi Murakami, Naoki Takahashi, Hiroyuki Ono, Kenji Nishimura, Masanori Tamaki, Kojiro Nagai, Hideharu Abe, Masayuki Iwano, Kensuke Joh and Toshio Doi : Glucocorticoid-dependent Tubulointerstitial Nephritis with IgM-positive Plasma Cells Presenting with Intracellular Crystalline Inclusions within the Rough Endoplasmic Reticulum., Internal Medicine, 2021. (Tokushima University Institutional Repository: 118015, DOI: 10.2169/internalmedicine.7118-21, PubMed: 33840699) |
|
6. | Kenji Nishimura, Kensei Taguchi, Seiji Kishi, R Craig Brooks, Arisa Ochi, Hiroyuki Kadoya, Yasumasa Ikeda, Masashi Miyoshi, Masanori Tamaki, Hideharu Abe, Ken-Ichi Aihara, Naoki Kashihara and Kojiro Nagai : Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and senescence after injury., Biochemical and Biophysical Research Communications, Vol.556, 142-148, 2021. (DOI: 10.1016/j.bbrc.2021.03.111, PubMed: 33845306) |
|
7. | Taichi Murakami, Kenji Nishimura, Hiroyuki Ono, Sayo Ueta, Eriko Shibata, Seiji Kishi, Masanori Tamaki, Keiko Miya, Hisato Shima, Manabu Tashiro, Tomoko Inoue, Kazuhiko Kawahara, Kojiro Nagai, Hideharu Abe, Jun Minakuchi and Toshio Doi : Clinical characteristics associated with 1-year tolvaptan efficacy in autosomal dominant polycystic kidney disease with a wide range of kidney functions., The Journal of Medical Investigation : JMI, Vol.67, No.3.4, 315-320, 2020. (Tokushima University Institutional Repository: 115436, DOI: 10.2152/jmi.67.315, PubMed: 33148908, Elsevier: Scopus) |
|
8. | Kenji Nishimura, Taichi Murakami, Toshihiro Sakurai, Masashi Miyoshi, Kiyoe Kurahashi, Seiji Kishi, Masanori Tamaki, Tatsuya Tominaga, Sumiko Yoshida, Kojiro Nagai, Hideharu Abe, Shu-Ping Hui, Kazuhiko Kotani and Toshio Doi : Circulating Apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolism., Scientific Reports, Vol.9, No.1, 14869, 2019. (Tokushima University Institutional Repository: 114663, DOI: 10.1038/s41598-019-51367-7, PubMed: 31619724) |
|
9. | Taichi Murakami, Masanori Tamaki, Seiji Kishi, Kojiro Nagai, Hideharu Abe, Yoshimi Bando, Yuko Toyoda, Hirokazu Ogino, Yasuhiko Nishioka, Sayo Ueda, Toshio Doi and Motokazu Matsuura : Systemic Sarcoidosis Presenting with Renal Involvement Caused by Various Sarcoidosis-associated Pathophysiological Conditions, Internal Medicine, Vol.58, No.5, 679-684, 2019. (Tokushima University Institutional Repository: 114405, DOI: 10.2169/internalmedicine.1558-18, PubMed: 30449791, Elsevier: Scopus) |
|
10. | Fumiaki Obata, Hideharu Abe, Taichi Murakami, Sayo Ueda, Taizo Inagaki, Masanori Minato, Hiroyuki Ono, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, Fumi Kishi, Seiji Kishi, Kojiro Nagai and Toshio Doi : Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis., CEN Case Reports, Vol.8, No.2, 134-138, 2019. (DOI: 10.1007/s13730-019-00381-9, PubMed: 30721455) |
|
11. | Masanori Tamaki, Tatsuya Tominaga, Yui Fujita, Yasuhiko Koezuka, Go Ichien, Taichi Murakami, Seiji Kishi, Keiichi Yamamoto, Hideharu Abe, Kojiro Nagai and Toshio Doi : All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element., American Journal of Physiology, Endocrinology and Metabolism, Vol.316, No.3, E418-E431, 2019. (DOI: 10.1152/ajpendo.00218.2018, PubMed: 30601699) |
|
12. | Eriko Shibata, Kojiro Nagai, Sayo Ueda, Hiroyuki Ono, Kenji Nishimura, Taizo Inagaki, Masanori Minato, Fumi Kishi, Masanori Tamaki, Taichi Murakami, Seiji Kishi, Hideharu Abe, Narushi Yokota, Jun Minakuchi and Toshio Doi : The utility and limitation of inferior vena cava diameter as a dry weight marker., The Journal of Medical Investigation : JMI, Vol.66, No.1.2, 172-177, 2019. (Tokushima University Institutional Repository: 113414, DOI: 10.2152/jmi.66.172, PubMed: 31064933) |
|
13. | Hideharu Abe, Akiko Sakurai, Hiroyuki Ono, Sanae Hayashi, Sakiya Yoshimoto, Arisa Ochi, Sayo Ueda, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, Fumi Kishi, Seiji Kishi, Taichi Murakami, Kojiro Nagai and Toshio Doi : Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy, The Journal of Medical Investigation : JMI, Vol.65, No.3.4, 208-215, 2018. (Tokushima University Institutional Repository: 112239, DOI: 10.2152/jmi.65.208, PubMed: 30282862, Elsevier: Scopus) |
|
14. | Hiroyuki Ono, Hideharu Abe, Akiko Sakurai, Arisa Ochi, Tatsuya Tominaga, Masanori Tamaki, Seiji Kishi, Taichi Murakami, Kojiro Nagai, Masayuki Kohashi and Toshio Doi : Novel Interplay Between Smad1 and Smad3 Phosphorylation via AGE Regulates the Progression of Diabetic Nephropathy., Scientific Reports, Vol.8, No.1, 2018. (Tokushima University Institutional Repository: 112878, DOI: 10.1038/s41598-018-28439-1, PubMed: 30002389) |
|
15. | Seiji Kishi, 小幡 史明, Hirokazu Miki, Motokazu Matsuura, Masanori Tamaki, Fumi Kishi, 西村 賢二, Taichi Murakami, Hideharu Abe, Kojiro Nagai, Masahiro Abe and Toshio Doi : A case of Lambda Light Chain Noncrystalline Proximal Tubulopathy with IgD lambda myeloma, Internal Medicine, 2018. (Tokushima University Institutional Repository: 114401, DOI: 10.2169/internalmedicine.1323-18, PubMed: 30101939) |
|
16. | Seiji Kishi, Masanori Minato, Atsuro Saijo, Naoka Murakami, Masanori Tamaki, Motokazu Matsuura, Taichi Murakami, Kojiro Nagai, Hideharu Abe, Yasuhiko Nishioka and Toshio Doi : IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma., Internal Medicine, Vol.57, No.9, 1259-1263, 2018. (Tokushima University Institutional Repository: 114399, DOI: 10.2169/internalmedicine.9814-17, PubMed: 29279511, Elsevier: Scopus) |
|
17. | Kojiro Nagai, Hiroyuki Ono, Motokazu Matsuura, Michael Hann, Sayo Ueda, Sakiya Yoshimoto, Masanori Tamaki, Taichi Murakami, Hideharu Abe, Hisashi Ishikura and Toshio Doi : Progressive renal insufficiency related to ALK inhibitor, alectinib., Oxford Medical Case Reports, Vol.2018, No.4, 2018. (DOI: 10.1093/omcr/omy009, PubMed: 29713488) |
|
18. | Fumi Kishi, Kojiro Nagai, Norimichi Takamatsu, Tatsuya Tominaga, Masanori Tamaki, E. Shibata, Taichi Murakami, Seiji Kishi, Hideharu Abe, Y Koezuka, N Minagawa, G Ichien and Toshio Doi : Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational study., PLoS ONE, Vol.13, No.4, e0195523, 2018. (Tokushima University Institutional Repository: 112361, DOI: 10.1371/journal.pone.0195523, PubMed: 29624611) |
|
19. | Hiroyuki Ono, Kojiro Nagai, Eriko Shibata, Motokazu Matsuura, Seiji Kishi, Taizo Inagaki, Masanori Minato, Sakiya Yoshimoto, Sayo Ueda, Fumiaki Obata, Kenji Nishimura, Masanori Tamaki, Fumi Kishi, Taichi Murakami, Hideharu Abe, Yukiko Kinoshita, Maki Urushihara, Shoji Kagami and Toshio Doi : Re-recognition of Age-dependent Reference Range for the Serum Creatinine Level in Teenagers - A Case of Slowly Progressive Tubulointerstitial Nephritis which Occurred in an Adolescent., Internal Medicine, Vol.56, No.16, 2187-2193, 2017. (Tokushima University Institutional Repository: 114406, DOI: 10.2169/internalmedicine.8599-16, PubMed: 28781321) |
|
20. | Hiroyuki Ono, Taichi Murakami, Akira Mima, Eriko Shibata, Masanori Tamaki, Sakiya Yoshimoto, Sayo Ueda, Fumi Kishi, Seiji Kishi, Takashi Kawanaka, Motokazu Matsuura, Kojiro Nagai, Hideharu Abe, Masashi Harada and Toshio Doi : Successful treatment of highly advanced immunoglobulin G4-related kidney disease presenting renal mass-like regions with end-stage kidney failure: a case study., BMC Nephrology, Vol.18, No.1, 261, 2017. (Tokushima University Institutional Repository: 114372, DOI: 10.1186/s12882-017-0676-5, PubMed: 28774276) |
|
21. | Fumiaki Obata, Taichi Murakami, Junko Miyagi, Sayo Ueda, Taizo Inagaki, Masanori Minato, Hiroyuki Ono, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, Sakiya Yoshimoto, Fumi Kishi, Seiji Kishi, Motokazu Matsuura, Kojiro Nagai, Hideharu Abe and Toshio Doi : A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressant., CEN Case Reports, Vol.6, No.1, 55-60, 2016. (DOI: 10.1007/s13730-016-0244-z, PubMed: 28509128) |
1. | Masanori Tamaki and Shu Wakino : 増大号 AKI·CKDの診断·治療に臨床検査を活かせ 4章 腎疾患を知る-臨床検査ができること 臨床検査で迫る腎疾患 糖尿病性腎症·腎臓病と腎硬化症, Journal of Medical Technology, Vol.68, No.4, 524-527, Apr. 2024. (DOI: 10.11477/mf.1542203599, CiNii: 1390581003357831808) |
|
2. | Shu Wakino, Masanori Tamaki and Eriko Shibata : 特集 微量元素 みいつけた : 生理作用・疾患・くすりと食品にクローズアップ! ; 場面別! 知っておきたい欠乏症とその予防・治療の方法, The Journal of Practical Pharmacy, Vol.75, No.3, 346-350, Mar. 2024. (CiNii: 1520299596038519296) |
|
3. | Kazuhiro Hasegawa, Masanori Tamaki, Eriko Shibata, Masanori Minato, Taizo Inagaki, 清水 郁子, 山口 純代, 宮上 慎司, 多田 美穂 and Shu Wakino : 特集 糖尿病性腎症研究の最前線 糖尿病性腎症の発症機序 糖尿病性腎症におけるミトコンドリアの役割, Kidney and Dialysis, Vol.96, No.2, 159-164, Feb. 2024. (DOI: 10.24479/kd.0000001187, CiNii: 1390299528381041664) |
|
4. | Shu Wakino, Kazuhiro Hasegawa, Masanori Tamaki and Eriko Shibata : 特集 血液透析患者の血圧を再考する 5.透析患者の至適血圧-腹膜透析も含む, The Japanese Journal of Clinical Dialysis, Vol.40, No.2, 155-163, Feb. 2024. (DOI: 10.19020/cd.0000002887, CiNii: 1390862168254226944) |
|
5. | Masanori Tamaki : 特集 新型コロナウイルス感染症の検証-腎疾患診療を中心に コロナ禍での腎疾患診療 地域で透析患者を守る医療連携, Kidney and Dialysis, Vol.95, No.4, 473-476, Oct. 2023. (DOI: 10.24479/kd.0000000911, CiNii: 1390579454818335744) |
|
6. | Masanori Tamaki : 特集 診断の糸口はここにある 手がかりから紐解く臨床推論 第8章 腎臓 [Case 8 意識障害]なんか⋯⋯ぼーっと⋯⋯, Internal Medicine, Vol.132, No.3, 613-615, Sep. 2023. (DOI: 10.15106/j_naika132_613, CiNii: 1390015730587544960) |
|
7. | Masanori Tamaki : 特集 診断の糸口はここにある 手がかりから紐解く臨床推論 第8章 腎臓 [Case 7 意識障害]ぼーっとして集中できません, Internal Medicine, Vol.132, No.3, 610-612, Sep. 2023. (DOI: 10.15106/j_naika132_610, CiNii: 1390578680541012736) |
|
8. | Shu Wakino, Kazuhiro Hasegawa and Masanori Tamaki : 近位尿細管から見た糖尿病性腎臓病と肥満関連腎症, Cardioangiology, Vol.93, No.2, 182-189, Feb. 2023. (CiNii: 1520013962704009344) |
|
9. | Masanori Tamaki, Kazuhiro Hasegawa and Shu Wakino : 【急性腎障害(AKI)】AKIの病態とその対応 手術とAKI, Kidney and Dialysis, Vol.94, No.1, 83-86, Jan. 2023. (DOI: 10.24479/kd.0000000586, CiNii: 1390016195131521024) |
|
10. | Masanori Tamaki and Shu Wakino : 透析患者の血圧はどこまで下げるべきでしょうか?, Internal Medicine, Vol.130, No.3, 612-614, Sep. 2022. (DOI: 10.15106/j_naika130_612, CiNii: 1390293180218739584) |
|
11. | Kazuhiro Hasegawa, Masanori Tamaki, 坂巻 裕介 and Shu Wakino : ミトコンドリアとSIRT1/NMNと腎臓病, Nephrology, Vol.15, No.5, 551-557, May 2022. (CiNii: 1520292395539278336) |
1. | Masanori Tamaki, Tatsuya Tominaga, Yui Fujita, Taichi Murakami, Seiji Kishi, Hideharu Abe, Kojiro Nagai and Toshio Doi : A Novel All-Trans Retinoic Acid Therapy Directly Suppresses Bone Morphogenetic Protein 4 in Mouse Diabetic Nephropathy, KIDNEY WEEK 2019 American Society of Nephrology, Nov. 2019. |
|
2. | Kenji Nishimura, Seiji Kishi, Arisa Ochi, Hiroyuki Ono, Masanori Tamaki, Taichi Murakami, Hideharu Abe, Kenichi Aihara and Kojiro Nagai : Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and aging after injury, KIDNEY WEEK 2019 American Society of Nephrology, Nov. 2019. |
|
3. | Masanori Tamaki, Taizo Inagaki, Masanori Minato, Fumi Kishi, Seiji Kishi, Taichi Murakami, Kojiro Nagai, Hideharu Abe and Toshio Doi : A case of Helicobacter cinaedi-induced PD-related peritonitis detected by blood culture, APCM-ISPD2019, Sep. 2019. |
|
4. | Seiji Kishi, Kenji Nishimura, Hiroyuki Ono, Masanori Tamaki, Fumi Kishi, Taichi Murakami, Hideharu Abe and Kojiro Nagai : ENHANCED KIDNEY FIBROSIS AND AGING AFTER UUO IN ENOS/APOE DOUBLE KNOCKOUT MOUSE, 56th ERA-EDTA Congress, Jun. 2019. |
|
5. | Maho Iwaki, Seiji Kishi, Masanori Minato, Masanori Tamaki, Fumi Kishi, Taichi Murakami, Hideharu Abe and Kojiro Nagai : Glomerular Injury Related to Immune Related Adverse Events: IgA Nephropathy After Nivolumab Therapy for Postoperative Recurrence of Lung Cancer, ASN Kidney week 2018, San Diego, Oct. 2018. |
|
6. | Masanori Tamaki, Tatsuya Tominaga, Yui Fujita, Seiji Kishi, Taichi Murakami, Kojiro Nagai, Hideharu Abe and Toshio Doi : Mesangial Matrix Expansion Attenuated by All-Trans Retinoic Acid Through Direct Suppression of Bone Morphogenetic Protein 4 in Mouse Diabetic Nephropathy, KIDNEY WEEK 2018 American Society of Nephrology, Oct. 2018. |
|
7. | Yui Fujita, Tatsuya Tominaga, Masanori Tamaki, Taichi Murakami, Seiji Kishi, Kojiro Nagai, Hideharu Abe and Toshio Doi : Palovarotene, Selective Retinoic Receptor- Agonist, Inhibited Both BMP4 and TGF- Signaling Pathways in Diabetic Nephropathy, KIDNEY WEEK 2017 American Society of Nephrology, Nov. 2017. |
|
8. | Masanori Tamaki, Tatsuya Tominaga, Yui Fujita, Seiji Kishi, Taichi Murakami, Kojiro Nagai, Hideharu Abe and Toshio Doi : Glomerulosclerosis Attenuated by Retinoic Acid through Bone Morphogenetic Protein 4 Suppression in Mice with Streptozotocin-Induced Diabetes, KIDNEY WEEK 2017 American Society of Nephrology, Nov. 2017. |
1. | Shu Wakino, 柴田 理恵子, Kazuhiro Hasegawa, Masanori Tamaki, Masanori Minato, Taizo Inagaki, 宮上 慎司, 多田 美穂 and Ichiro Hashimoto : 皮膚虚血・潰瘍病変患者における血中亜鉛濃度の意義, 第53回徳島透析療法研究会, Dec. 2023. |
|
2. | 宮上 慎司, Masanori Tamaki, Miho Tada, 山口 純代 and Shu Wakino : ステロイドとリツキシマブが奏功したキャッスルマン病合併HIV関連免疫複合体腎臓病の一例, Japanese Journal of Nephrology, Vol.65, No.6-W, 744, Sep. 2023. |
|
3. | 山口 純代, Masanori Tamaki, 宮上 慎司, Eriko Shibata and Shu Wakino : アンモニア除去に苦慮した55歳発症尿素サイクル異常症の1例, Journal of Japanese Society for Dialysis Therapy, Vol.56, No.Suppl.1, 431, May 2023. |
|
4. | Shu Wakino, Kazuhiro Hasegawa and Masanori Tamaki : AKD(acute kidney disease and disorders)を考える 透析導入阻止のためのAKD治療戦略, Japanese Journal of Nephrology, Vol.65, No.3, 231, May 2023. |
|
5. | Masanori Tamaki, 越智 ありさ, Tatsuya Tominaga, Eriko Shibata and Shu Wakino : Parkinは糖尿病やBMP4が惹起するミトコンドリアターンオーバー障害の治療標的である, Japanese Journal of Nephrology, Vol.65, No.3, 251, May 2023. |
|
6. | Kazuhiro Hasegawa, Masanori Tamaki and Shu Wakino : 心血管内分泌の新知見 尿細管糸球体連関とDKD, Folia endocrinologica Japonica, Vol.99, No.1, 171, May 2023. |
|
7. | Masanori Minato, Ikuko Shimizu, Masanori Tamaki, Kazuhiro Hasegawa and Shu Wakino : 長時間のAPDにより至適透析を得た重度の精神発達遅滞を有する一例, Journal of Japanese Society for Dialysis Therapy, Vol.56, No.Suppl.1, 563, 2023. |
|
8. | 林 成樹, Ryohei Sumitani, Masahiro Oura, Takeshi Harada, Shingen Nakamura, Ayaka Mori, Masanori Tamaki and Masahiro Abe : ITP,自己免疫性出血病F13に続発しTAFRO症候群を発症した1例, 第127回日本内科学会四国地方会, Dec. 2022. |
|
9. | Yohjiroh Sunada, Sayo Ueda, Masanori Tamaki, Eriko Shibata and Shu Wakino : 胃癌による二次性血栓性微小血管症(TMA)の一例, Shikoku Acta Medica, Vol.78, No.5-6, 257-258, Dec. 2022. |
|
10. | Kazuhiro Hasegawa, Masanori Tamaki and Shu Wakino : 時間空間的ネットワークで考えるDKDの基礎研究 尿細管糸球体クロストークとDKD, Japanese Journal of Nephrology, Vol.64, No.6-W, 696, Oct. 2022. |
|
11. | Masanori Tamaki, 宮上 慎司, Ikuko Shimizu, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino : ロキサデュスタット投与後に奇異性脳塞栓を発症した1例, Japanese Journal of Nephrology, Vol.64, No.6-W, 719, Oct. 2022. |
|
12. | 宮上 慎司, Masanori Tamaki, Ikuko Shimizu, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino : コロナウィルスワクチン後発症した悪性腎硬化症の一例, Japanese Journal of Nephrology, Vol.64, No.6-W, 719, Oct. 2022. |
|
13. | Kazuhiro Hasegawa, Masanori Tamaki, 坂巻 裕介 and Shu Wakino : 腎臓病治療に対する新たな切り口 DMミトコンドリア機能改善薬やNADがDKDのみならず腎臓病への切り口となる可能性, Japanese Journal of Nephrology, Vol.64, No.3, 189, May 2022. |
|
14. | Kazuhiro Hasegawa, Masanori Tamaki, 坂巻 裕介 and Shu Wakino : NMN消費酵素Nmnatのポドサイト発現調節はE-boxへのepigenetic制御が担う, Japanese Journal of Nephrology, Vol.64, No.3, 228, May 2022. |
|
15. | Masanori Tamaki, 宮上 慎司, Ikuko Shimizu, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Motoyuki Tamaki, Motoyuki Tamaki, Kazuhiro Hasegawa, Kojiro Nagai and Shu Wakino : ESAからロキサデュスタットへ切り替えた保存期CKD症例の解析, Japanese Journal of Nephrology, Vol.64, No.3, 257, May 2022. |
|
16. | Kazuhiro Hasegawa, Masanori Tamaki, 坂巻 裕介 and Shu Wakino : FSGSへのNMN短期集中投与はNMN・NAD消費酵素の暴走連関を抑制し糸球体硬化を抑止する, Japanese Journal of Nephrology, Vol.64, No.3, 263, May 2022. |
|
17. | Sayo Ueda, Eriko Shibata, Masanori Tamaki, Masanori Minato, 岩城 真帆, Ikuko Shimizu, 山口 純代, 宮上 慎司, Kazuhiro Hasegawa and Shu Wakino : 急性間質性腎炎を認めた敗血症性AKIの症例, Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl.1, 507, May 2022. |
|
18. | Masanori Tamaki, 宮上 慎司, 岩城 真帆, Ikuko Shimizu, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Kojiro Nagai, Kazuhiro Hasegawa and Shu Wakino : 腹膜透析導入後に膵癌を発症した1例, Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl.1, 631, May 2022. |
|
19. | Ikuko Shimizu, Masanori Tamaki, 宮上 慎司, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino : 慢性大動脈解離に伴う慢性DICのため腎代替療法導入に苦慮した1例, Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl.1, 663, May 2022. |
|
20. | Masanori Tamaki, 宮上 慎司, 岩城 真帆, 清水 郁子, 山口 純代, 湊 将典, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa, Kojiro Nagai and Shu Wakino : 膵癌を合併した腹膜透析患者の1例, 第27回日本腹膜透析医学会学術集会・総会, Oct. 2021. |
|
21. | 宮上 慎司, Masanori Tamaki, Kenji Nishimura, 岩城 真帆, 清水 郁子, 山口 純代, Sayo Ueda, Eriko Shibata, Hideharu Abe, Kojiro Nagai and Shu Wakino : 繰り返す菌血症に対し予防的抗菌薬投与が奏功した1例, Journal of Japanese Society for Dialysis Therapy, Jun. 2021. |
|
22. | Seiji Kishi, Kenji Nishimura, Masanori Tamaki, Fumi Kishi, Eriko Shibata, Taichi Murakami and Kojiro Nagai : 血液透析導入期の僧帽弁感染性心内膜炎による敗血症性肺塞栓 Embolism from left to right-sided heart, Journal of Japanese Society for Dialysis Therapy, Vol.53, No.Suppl.1, 481, Oct. 2020. |
|
23. | Masanori Tamaki, 湊 将典, Sayo Ueda, Eriko Shibata, Kenji Nishimura, Hiroyuki Ono, 小幡 史明, 山本 修三, 滝下 佳寛, 田蒔 正治, Hideharu Abe and Kojiro Nagai : 急性期と慢性期ともにトシリズマブが有効であったTAFRO症候群の1例, Journal of Japanese Society for Dialysis Therapy, Vol.53, No.Suppl.1, 391, Oct. 2020. |
|
24. | Eriko Shibata, 三好 雅士, Takayuki Nakao, Sayo Ueda, Kenji Nishimura, Hiroyuki Ono, Fumi Kishi, Masanori Tamaki, Taichi Murakami, Hideharu Abe, Seiji Kishi, Toshio Doi and Kojiro Nagai : プレセプシン濃度は検体処理や腎機能障害により影響をうける, 第63回日本腎臓学会学術総会, Aug. 2020. |
|
25. | Masanori Tamaki, Hiroyuki Ono, Kenji Nishimura, Eriko Shibata, Sayo Ueda, 越智 ありさ, Tatsuya Tominaga, Kojiro Nagai and Hideharu Abe : 骨形成因子4(BMP4)はメサンギウム細胞のミトコンドリア障害を惹起する, Japanese Journal of Nephrology, Vol.62, No.4, 282, Jul. 2020. |
|
26. | 山崎 佳那子, Mio Yada, Yoshihiro Matsudate, Yoshiaki Kubo and Masanori Tamaki : Sore thumb症候群の1例, The Nishinihon Journal of Dermatology, Vol.82, No.2, 119, Apr. 2020. |
|
27. | Masanori Tamaki : 慢性腎臓病と生活習慣, 腎疾患二次検診認定医取得講習会, Feb. 2020. |
|
28. | 山口 純代, 岩城 真帆, 清水 郁子, 稲垣 太造, 湊 将典, Hiroyuki Ono, Sayo Ueda, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, Kojiro Nagai and Hideharu Abe : 全身倦怠感,呼吸困難感を生じ,その後急性高Ca血症と判明した透析患者の一例, 第47回徳島透析療法研究会, Nov. 2019. |
|
29. | Masanori Tamaki : 糖尿病性腎症重症化予防のためになすべきこと 治療も含めて ―腎臓内科の立場から―, 徳島県糖尿病性腎症重症化予防対策フォーラム, Oct. 2019. |
|
30. | 湊 将典, Taichi Murakami, Sayo Ueda, Hiroyuki Ono, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, Kojiro Nagai and Hideharu Abe : Fanconi症候群を合併したTubulointerstitial nephritis with IgM-positive plasma cellsの一例, 第49回日本腎臓学会西部学術大会, Oct. 2019. |
|
31. | 清水 郁子, Kojiro Nagai, 稲垣 太造, 湊 将典, 岩城 真帆, 山口 純代, Sayo Ueda, Kenji Nishimura, Hiroyuki Ono, Eriko Shibata, Masanori Tamaki, Fumi Kishi, Taichi Murakami, Seiji Kishi and Hideharu Abe : 慢性B型肝炎治療中に緩徐に進行する腎機能障害をみとめた一例, 第49回日本腎臓学会西部学術大会, Oct. 2019. |
|
32. | 近藤 広宗, Masanori Tamaki, 湊 将典, 稲垣 太造, Eriko Shibata, Kenji Nishimura, Hiroyuki Ono, Taichi Murakami, Hideharu Abe and Kojiro Nagai : 早期診断に基づく分子標的薬治療で救命しえたTAFRO症候群の1例, 第49回日本腎臓学会西部学術大会, Oct. 2019. |
|
33. | Seiji Kishi, Hiroyuki Ono, 稲垣 太造, 湊 将典, Kenji Nishimura, Fumi Kishi, Sayo Ueda, Eriko Shibata, Masanori Tamaki, Taichi Murakami, Hideharu Abe and Kojiro Nagai : PR-3 ANCA陽性化膿性脊椎炎合併シャント腎炎の1例, 第49回日本腎臓学会西部学術大会, Oct. 2019. |
|
34. | 山口 純代, 岩城 真帆, 清水 郁子, 稲垣 太造, 湊 将典, Hiroyuki Ono, Sayo Ueda, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, Kojiro Nagai, Masuda shiho, Itsuro Endo and Hideharu Abe : 透析導入期に急性高Ca血症を生じた一例, 第49回日本腎臓学会西部学術大会, Oct. 2019. |
|
35. | 田蒔 正治, 山本 修三, 滝下 佳寛, Masanori Tamaki, 藤井 泰宏, 安藤 道夫 and 増田 壽志 : 当院におけるエテルカルセチドの使用経験, 第53回 四国透析療法研究会, Oct. 2019. |
|
36. | Masanori Tamaki : 慢性腎臓病と生活習慣, 令和元年度 健康を考える県民のつどい, Sep. 2019. |
|
37. | Masanori Tamaki : 慢性腎臓病における高血圧管理の意義, 徳島透析療法研究会学術講演会, Aug. 2019. |
|
38. | 岸田 盛吾, Masanori Tamaki, 稲垣 太造, 湊 将典, Fumi Kishi, Seiji Kishi, Taichi Murakami, Hideharu Abe and Kojiro Nagai : 血液培養でHelicobacter cinaediを同定した排液培養陰性腹膜透析関連腹膜炎の一例, 第259回徳島医学会学術集会, Aug. 2019. |
|
39. | 黒澤 すみれ, 清水 郁子, 稲垣 太造, 湊 将典, 岩城 真帆, 山口 純代, 上田 紗代, Kenji Nishimura, Hiroyuki Ono, Eriko Shibata, Masanori Tamaki, Hideharu Abe, 早渕 修 and Kojiro Nagai : B型肝炎治療薬によって緩徐に腎機能悪化をみとめた一例, 第259回徳島医学会学術集会, Aug. 2019. |
|
40. | Masanori Tamaki : 慢性腎臓病と貧血とその他, 鳥居薬品株式会社 社内勉強会, Jul. 2019. |
|
41. | Masanori Tamaki : 慢性腎臓病と貧血管理, 名西郡・西医師会学術講演会, Jul. 2019. |
|
42. | Masanori Tamaki : 慢性腎臓病と貧血と高齢化社会, 協和発酵キリン株式会社 社内講演会, Jul. 2019. |
|
43. | Kenji Nishimura, Seiji Kishi, Hiroyuki Ono, Fumi Kishi, Masanori Tamaki, Taichi Murakami, Hideharu Abe and Kojiro Nagai : 生活習慣病リスク増加は腎臓の線維化と老化を加速する, 第62回日本腎臓学会学術総会, Jun. 2019. |
|
44. | Hiroyuki Ono, Hideharu Abe, Masanori Tamaki, Tatsuya Tominaga, Fumi Kishi, Seiji Kishi, Taichi Murakami, Kojiro Nagai and Toshio Doi : Smad1とSmad3の新規相互リン酸化制御機構による糖尿病性腎症の病態解析, 第62回日本腎臓学会学術総会, Jun. 2019. |
|
45. | Kenji Nishimura, Taichi Murakami, Hiroyuki Ono, Sayo Ueda, Eriko Shibata, Masanori Tamaki, Seiji Kishi, Kojiro Nagai, Hideharu Abe and Toshio Doi : 血中HDLアポ蛋白ApoL1はインスリンシグナルに制御され2型糖尿病における糸球体濾過量と相関する, 第62回日本腎臓学会学術総会, Jun. 2019. |
|
46. | Taichi Murakami, Hiroyuki Ono, 島 久登, 田代 学, 井上 朋子, Masanori Tamaki, 川原 和彦, Seiji Kishi, Kojiro Nagai, Hideharu Abe, 水口 潤 and Toshio Doi : ADPKDにおけるトルバプタン治療反応性と臨床的特徴についての検討, 第62回日本腎臓学会学術総会, Jun. 2019. |
|
47. | 荒瀬 美晴, Kojiro Nagai, 稲垣 太造, Eriko Shibata, Fumi Kishi, Masanori Tamaki, Taichi Murakami, Seiji Kishi, Hideharu Abe and Motokazu Matsuura : 尿蛋白減少にシクロスポリンが有効であったアルポート症候群の1例, 日本内科学会第119回四国地方会, Dec. 2018. |
|
48. | Taichi Murakami, Fumi Kishi, Masanori Tamaki, Kojiro Nagai, Hideharu Abe, Seiji Kishi, 湊 将典 and Sayo Ueda : Fanconi症候群を合併したTubulointerstitial nephritis with IgM-positive plasma cellsの一例, 第119回四国地方会, Dec. 2018. |
|
49. | Masanori Tamaki : よくわかるPD合併症の予防と対策, 第24回日本腹膜透析医学会学術集会・総会, Oct. 2018. |
|
50. | 岡田 衣世, Masanori Tamaki, 稲垣 太造, 湊 将典, Fumi Kishi, Seiji Kishi, Taichi Murakami, Kojiro Nagai, Hideharu Abe and Toshio Doi : 血液培養でHelicobacter cinaediを同定した廃液培養陰性PD関連腹膜炎の一例, 第24回日本腹膜透析医学会学術集会・総会, Oct. 2018. |
|
51. | Kenji Nishimura, Masanori Tamaki, Fumi Kishi, Taichi Murakami, Seiji Kishi, Kojiro Nagai, Hideharu Abe and Toshio Doi : 適切な腹膜透析廃液培養が早期診断・治療により有用であった真菌性腹膜炎の1例, 第24回日本腹膜透析医学会学術集会・総会, Oct. 2018. |
|
52. | Masanori Tamaki, 湊 将典, 稲垣 太造, Taichi Murakami, Seiji Kishi, Kojiro Nagai, Hideharu Abe and Toshio Doi : 腎盂腎炎と鑑別困難であった化膿性脊椎炎に感染後腎炎の合併が疑われた1例, 第48回日本腎臓学会西部学術大会, Sep. 2018. |
|
53. | Hiroyuki Ono, Kojiro Nagai, 松浦 元一, 稲垣 太造, 湊 将典, Sayo Ueda, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, 岸 史, Taichi Murakami, Seiji Kishi, 水口 潤, Hideharu Abe and Toshio Doi : ALK阻害薬関連の進行性腎障害を呈した1例, 第48回日本腎臓学会西部学術大会, Sep. 2018. |
|
54. | Taichi Murakami, Fumi Kishi, Masanori Tamaki, Seiji Kishi, Kojiro Nagai and Hideharu Abe : 多彩な腎病変を合併し細胞表面マーカー染色により肉芽腫性間質性腎炎を診断しえた腎サルコイドーシスの一例, 第48回日本腎臓学会西部学術集会, Sep. 2018. |
|
55. | Taichi Murakami, Fumi Kishi, Masanori Tamaki, Seiji Kishi, Kojiro Nagai and Hideharu Abe : 血栓性微小血管症による急性腎障害で末期腎不全に至ったクリオグロブリン血管炎の一例, 第48回日本腎臓学会西部学術集会, Sep. 2018. |
|
56. | 宮上 慎司, Hiroyuki Ono, Seiji Kishi, Eiji Kondou, Nobuhito Naitoh, 稲垣 太造, 湊 将典, 上田 紗代, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, Fumi Kishi, Taichi Murakami, Hideharu Abe, Yasuhiko Nishioka and Kojiro Nagai : ANCA関連血管炎との鑑別を要したIgG4関連疾患の1例, 第257回徳島医学会学術集会, Aug. 2018. |
|
57. | Fumi Kishi, Kojiro Nagai, Tatsuya Tominaga, Masanori Tamaki, 柴田 恵理子, Taichi Murakami, Seiji Kishi, 肥塚 靖彦, 皆川 直人, 一圓 剛, Norimichi Takamatsu and Toshio Doi : 尿中IV型コラーゲンは非糖尿病一般住民における糸球体濾過率低下に関与する, 第61回日本腎臓学会学術総会, Jun. 2018. |
|
58. | Masanori Tamaki, Tatsuya Tominaga, 藤田 結衣, Fumi Kishi, Seiji Kishi, Taichi Murakami, Kojiro Nagai, Hideharu Abe and Toshio Doi : レチノイン酸はBmp4遺伝子発現を直接制御して糖尿病マウスの糸球体硬化を改善する, 第61回日本腎臓学会学術総会, Jun. 2018. |
|
59. | 西村 賢二, Seiji Kishi, Masanori Tamaki, Taichi Murakami, Kojiro Nagai, Hideharu Abe and Toshio Doi : 血液透析導入期に発症した左心系感染性心内膜炎の1例, 第48回徳島透析療法研究会, Nov. 2017. |
|
60. | Hiroyuki Ono, Hideharu Abe, 上田 紗代, Kenji Nishimura, Masanori Tamaki, Taichi Murakami, Seiji Kishi, Kojiro Nagai and Toshio Doi : 糖尿病性腎症の糸球体硬化抑制過程におけるSmad1の新規リン酸化部位の同定と解析, 第255回徳島医学会学術集会, Aug. 2017. |
|
61. | Taichi Murakami, 稲垣 太造, 湊 将典, Eriko Shibata, Kenji Nishimura, Hiroyuki Ono, 上田 紗代, Masanori Tamaki, 岸 史, Seiji Kishi, Kojiro Nagai, Hideharu Abe and Toshio Doi : 過粘稠症候群に血漿交換が奏功した原発性マクログロブリン血症の一例, 第62回日本透析医学会学術集会, Jun. 2017. |
|
62. | Hiroyuki Ono, Taichi Murakami, 稲垣 太造, 上田 紗代, Eriko Shibata, Masanori Tamaki, 岸 史, Motokazu Matsuura, Seiji Kishi, Kojiro Nagai, Hideharu Abe and Toshio Doi : クリオグロブリン血栓性血管炎に続発した二次性血栓性微少血管症(TMA)に対して血漿交換,血液透析,ステロイド治療で救命しえた一例, 第62回日本透析医学会学術集会, Jun. 2017. |
|
63. | Taichi Murakami, Toshio Doi, Hideharu Abe, Motokazu Matsuura, Kojiro Nagai, Sakiya Yoshimoto, Seiji Kishi, 上田 紗代, 小野 広幸 and Masanori Tamaki : 徳島大学腎臓内科における多発性嚢胞腎患者の診療現況, 第114回内科学会四国地方会, May 2016. |
|
64. | Hiroyuki Ono, 平野 隆弘, Akiko Sakurai, 新井 美存, 上田 紗代, Eriko Shibata, Sakiya Yoshimoto, Masanori Tamaki, Motokazu Matsuura, Taichi Murakami, Kojiro Nagai, Toshio Doi and Hideharu Abe : E2A新規結合分子FLASHによるTNFα-p21制御と細胞増殖・老化の調整による腎炎の修復機構, 第6回分子腎臓フォーラム, Sep. 2015. |
|
65. | Taichi Murakami, Kojiro Nagai, Motokazu Matsuura, Masanori Tamaki, Eriko Shibata, Sakiya Yoshimoto, Hiroyuki Ono, 上田 紗代, Hideharu Abe and Toshio Doi : Trophoblast glycoprotein:ポドサイト障害における発現・機能解析および尿中マーカーとしての検討, 第58回日本腎臓学会学術総会, Jun. 2015. |
|
66. | Hiroyuki Ono, 平野 隆弘, Akiko Sakurai, 新井 美存, 上田 紗代, Eriko Shibata, Sakiya Yoshimoto, Masanori Tamaki, Motokazu Matsuura, Taichi Murakami, Kojiro Nagai, Toshio Doi and Hideharu Abe : E2A新規結合因子FLASHによるTNFα-P21制御と細胞増殖・老化の調整による腎炎の修復機構, 第58回日本腎臓学会学術総会, Jun. 2015. |
|
67. | Sakiya Yoshimoto, Kojiro Nagai, Hiroyuki Ono, Eriko Shibata, Sayo Ueda, Masanori Tamaki, Naoko Abe, Taichi Murakami, Akira Mima, Motokazu Matsuura, Hideharu Abe and Toshio Doi : サルコイドーシス,高カルシウム血症により間質障害を呈した一例, 第44回日本腎臓学会西部学術大会, Oct. 2014. |
|
68. | Hiroyuki Ono, Taichi Murakami, Motokazu Matsuura, Akira Mima, Sakiya Yoshimoto, Sayo Ueda, Masanori Tamaki, Eriko Shibata, Kojiro Nagai, Hideharu Abe and Toshio Doi : ループス腎炎との鑑別を要したIgG4関連腎症の1例, 第44回日本腎臓学会西部学術大会, Oct. 2014. |
1. | Masanori Tamaki, 湊 将典, 宮上 慎司, 岩城 真帆, 清水 郁子, 山口 純代, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino : ステントグラフト留置術がAVG頻回閉塞に有用であった一例, 第55回四国透析療法研究会, Oct. 2021. |
|
2. | 遠藤 理子, 宮上 慎司, 湊 将典, Masanori Tamaki, 岩城 真帆, 清水 郁子, 山口 純代, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino : 膜性腎症に合併したIgG4関連腎臓病の一例, 第263回徳島医学会, Aug. 2021. |